Alger Jason (CIK 1839111) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Sell HCAT (18,804 shares), Sell HCAT (26,970 shares), Buy HCAT (507,500 shares), Buy HCAT (22,222 shares), Sell HCAT (7,522 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Sell | 18,804 | $25,765 |
| 2026-03-05 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Sell | 26,970 | $44,770 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Buy | 507,500 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Buy | 22,222 | $0 |
| 2026-02-27 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Sell | 7,522 | $13,164 |
| 2025-12-03 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Sell | 20,619 | $59,795 |
| 2025-09-04 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Sell | 2,613 | $8,780 |
| 2025-06-03 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Sell | 2,712 | $9,845 |
| 2025-03-04 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Sell | 7,304 | $33,452 |
| 2025-02-24 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Buy | 181,000 | $0 |
| 2025-02-24 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | Buy | 11,950 | $0 |
Source: SEC Form 4 filings · as of 2026-06-03